| 1 | Mononeuritis multiplex associated with antiphospholipid antibodies | 2ᵒ autor y autor de correspondencia: Díaz Borjón A., Valdés Corona L.F. | 2020 | Archives of Rheumatology | WoS-id: 000520407500020
Scopus-id: 2-s2.0-85084683360
| 0 | 0 |
| 2 | Consenso multidisciplinario de diagnóstico, manejo farmacológico y no farmacológico de la osteoartritis y el papel del sulfato de glucosamina cristalino de prescripción como una nueva opción terapéutica | 1ᵉʳ autor: Díaz-Borjón A., D'Hyver-De Las Deses C., Espinosa-Morales R., Galleli L., et al. | 2020 | Medicina Interna De México | Scopus-id: 2-s2.0-85090033603
| 0 | 2 |
| 3 | Actualización de la Guía Mexicana para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología | 2ᵒ autor: Díaz-Borjón A., Cardiel M.H., Vázquez del Mercado Espinosa M., Gámez-Nava J.I., et al. | 2014 | Reumatologia Clinica | Scopus-id: 2-s2.0-84902793455
| 0 | 41 |
| 4 | Parvovirus B19 Associated Arthritis: Report on a Community Outbreak | 2ᵒ autor: Diaz-Borjon, A, Tello-Winniczuk, N, Diaz-Jouanen, E | 2011 | JOURNAL OF RHEUMATOLOGY | WoS-id: 000292534500235
| 0 | 0 |
| 5 | Parvovirus B19-Associated Arthritis Report on a Community Outbreak | Coautor y autor de correspondencia: Díaz-Borjón A., Tello-Winniczuk N., Díaz-Jouanen E. | 2011 | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | WoS-id: 000298133200012
Scopus-id: 2-s2.0-82455210705
| 9 | 12 |
| 6 | Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis | 1ᵉʳ autor y autor de correspondencia: Díaz-Borjón A. | 2009 | DRUG AGING | WoS-id: 000267243200001
Scopus-id: 2-s2.0-67649993328
| 22 | 27 |
| 7 | Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis | 2ᵒ autor: Diaz-Borjon A., Colmegna I., Fujii H., Schaefer L., et al. | 2008 | ARTHRITIS AND RHEUMATISM | WoS-id: 000255345200010
Scopus-id: 2-s2.0-42449085252
| 84 | 92 |
| 8 | The Ever-Expanding Association Between Rheumatologic Diseases and Tuberculosis | 2ᵒ autor: Díaz-Borjon A., Franco-Paredes C., Senger M.A., Barragan L., et al. | 2006 | AM J MED | WoS-id: 000238110500004
Scopus-id: 2-s2.0-33646905661
| 38 | 50 |
| 9 | Bisphosphonate-associated arthritis | 1ᵉʳ autor: Diaz-Borjon A., Seyler T.M., Chen N.L., Lim S.S. | 2006 | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | WoS-id: 000238138300007
Scopus-id: 2-s2.0-33748127944
| 15 | 12 |
| 10 | Treatment of chronic inflammatory diseases with biologic agents: Opportunities and risks for the elderly | 1ᵉʳ autor: Diaz-Borjon A., Weyand C.M., Goronzy J.J. | 2006 | EXPERIMENTAL GERONTOLOGY | WoS-id: 000243219800012
Scopus-id: 2-s2.0-33751515683
| 8 | 10 |
| 11 | Multifocal septic arthritis: An unusual complication of invasive Streptococcus pyogenes infection [2] | 1ᵉʳ autor: Diaz-Borjon A., Lim S., Franco-Paredes C. | 2005 | AM J MED | WoS-id: 000231037100022
Scopus-id: 2-s2.0-23244456773
| 2 | 3 |
| 12 | Multidrug resistance-I (MDR-I) in rheumatic autoimmune disorders - Part I: increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome | Coautor: Diaz-Borjon, A, Llorente, L, Richaud-Patin, Y, de la Barrera, CA, et al. | 2000 | Joint Bone Spine | WoS-id: 000086899000006
Scopus-id: 2-s2.0-0033625078
| 87 | 93 |
| 13 | Multidrug resistance-I (MDR-I) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control | 1ᵉʳ autor: Diaz-Borjon A., Richaud-Patin Y., Alvarado de la Barrera C., Jakez-Ocampo J., et al. | 2000 | REV RHUM | WoS-id: 000086899000007
Scopus-id: 2-s2.0-0033625072
| 47 | 57 |
| 14 | Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology | Coautor: Diaz-Borjón A., Llorente L., De La Fuente H., Richaud-Patin Y., et al. | 2000 | IMMUNOLOGY LETTERS | Scopus-id: 2-s2.0-0034328435
| 32 | 61 |
| 15 | Multidrug resistance-I (MDR-I) in rheumatic autoimmune disorders: Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control [Phénotype MDR-I de | 1ᵉʳ autor: Díaz-Borjón A., Richaud-Patin Y., Alvarado-De La Barrera C., Jakez-Ocampo J., et al. | 2000 | Revue du Rhumatisme (Edition Francaise) | Scopus-id: 2-s2.0-0347999564
| 0 | 0 |
| 16 | Multidrug resistance-I (MDR-I) in rheumatic autoimmune disorders: Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcomes [Phénotype MDR-I de multirésistance aux traiteme | Coautor: Díaz-Borjón A., Llorente L., Richaud-Patin Y., Alvarado-De La Barrera C., et al. | 2000 | Revue du Rhumatisme (Edition Francaise) | Scopus-id: 2-s2.0-0348003244
| 0 | 0 |
| 17 | Increased collagenase and dipeptidyl peptidase I activity in leucocytes from healthy elderly people | Coautor: Díaz-Borjón A., Llorente L., Richaud-Patin Y., Jakez-Ocampo J., et al. | 1999 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | WoS-id: 000081511100007
Scopus-id: 2-s2.0-0032993899
| 7 | 8 |
| 18 | Adherence to Current Vaccination Recommendations for Patients With Rheumatoid Arthritis in Mexico | Coautor y autor de correspondencia: Diaz-Borjon A., Cepeda-Perez A.S., Tello Winniczuk N. | | Reumatologia Clinica | WoS-id: 000644767900006
Scopus-id: 2-s2.0-85067856235
| 5 | 5 |
| 19 | Comorbidity burden in terms of disability in patients with osteoarthritis in Mexico. The IMPACTAR registry | Coautor: Díaz-Borjón A., Vega-Morales D., Esquivel-Valerio J.A., Vázquez-Fuentes B.R., et al. | | Reumatologia Clinica | WoS-id: 000715113700003
Scopus-id: 2-s2.0-85086564142
| 3 | 3 |
ID's SCOPUS 